Compounds > betaxolol
Page last updated: 2024-10-23

betaxolol and Local Neoplasm Recurrence

betaxolol has been researched along with Local Neoplasm Recurrence in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Preventively using topical betaxolol can significantly decrease the incidence, VAS score, and grading of EGFR-TKI-induced paronychia."8.02Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study. ( Chen, CB; Chen, KH; Chen, MJ; Chung, WH; Fang, YF; Hsu, PC; Ko, HW; Ko, YS; Li, SH; Lin, YJ; Lu, CW; Shih, FY; Su Pang, JH; Tseng, LC; Wang, CL; Wang, TY; Wu, CE; Yen, CF, 2021)
"Preventively using topical betaxolol can significantly decrease the incidence, VAS score, and grading of EGFR-TKI-induced paronychia."4.02Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study. ( Chen, CB; Chen, KH; Chen, MJ; Chung, WH; Fang, YF; Hsu, PC; Ko, HW; Ko, YS; Li, SH; Lin, YJ; Lu, CW; Shih, FY; Su Pang, JH; Tseng, LC; Wang, CL; Wang, TY; Wu, CE; Yen, CF, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lu, CW1
Wang, TY1
Yen, CF1
Chen, KH1
Wu, CE1
Wang, CL1
Hsu, PC1
Fang, YF1
Li, SH1
Ko, HW1
Tseng, LC1
Shih, FY1
Lin, YJ1
Chen, MJ1
Chen, CB1
Su Pang, JH1
Chung, WH1
Ko, YS1

Other Studies

1 other study available for betaxolol and Local Neoplasm Recurrence

ArticleYear
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study.
    International journal of dermatology, 2021, Volume: 60, Issue:2

    Topics: Antineoplastic Agents; Betaxolol; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cohort Studi

2021